Trials / Completed
CompletedNCT01692145
A Parallel Group Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes
A Randomized, Double Blind, Placebo Controlled, Parallel Group Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Kissei Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of KCT-0809 compared to placebo in patients with dry eye syndromes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | KCT-0809 | |
| DRUG | Placebo |
Timeline
- First posted
- 2012-09-25
- Last updated
- 2014-05-30
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01692145. Inclusion in this directory is not an endorsement.